Becton Dickinson Launches CentroVena One™ System Cutting Steps by 30%
BD launched its first all-in-one CentroVena One insertion system, consolidating catheter components into a single platform to simplify central line placement. The device cuts procedural steps by 30%, halves insertion time and reduces contamination risk through integrated safety features cleared by FDA Safer Technologies Program.
1. Product Launch and Features
BD has commercially launched the CentroVena One™ Insertion System, the first all-in-one central venous catheter insertion device. It integrates the introducer needle, syringe, guidewire and catheter into a single platform to streamline placement in acute care settings.
2. Performance and Safety Improvements
Compared to traditional CVC kits, CentroVena One reduces procedural steps by 30% and cuts insertion time by 50% in head-to-head simulations. Integrated passive needle safety, a pre-loaded guidewire with drape clip and a self-dilating tip minimize contamination, needlestick injuries and embolism risk.
3. Clinical Evaluation and Regulatory Recognition
UNC Health Blue Ridge began piloting the system in high-acuity environments, reporting streamlined workflows and fewer sterile field breaches. The device holds FDA 510(k) clearance and was accepted into the Safer Technologies Program for its substantial safety innovations.
4. Market Expansion and Strategic Implications
This launch marks BD’s entry into the acute CVC market, expanding its vascular access portfolio. The innovation aims to enhance clinical efficiency, reduce complications and drive revenue growth in BD’s IV therapy solutions.